The Pulse – Newsletter for Leaders in the Medical Device Industry – April 2007
April 10, 2007
The rapidly changing legislative, reimbursement, regulatory, and technology landscapes, coupled with increasing civil and criminal liability, have posed significant challenges and offered tremendous opportunities for medical device manufacturers.
To help you address these developments, the Medical Device attorneys of Foley & Lardner LLP provide fully integrated experience in U.S. Food and Drug Administration (FDA) and health care regulatory issues, reimbursement, intellectual property law (IP), business law, litigation, and public affairs, enabling us to collaboratively craft effective strategies and implement them with clients.
Read The Pulse newsletter by clicking on the link below.
Author(s)
Related Insights
May 30, 2025
Foley Career Perspectives
Foley Mental Health Month Program: Enhancing Performance Through High-Quality Connections
Foley & Lardner endeavors to create a high-performance culture that also prioritizes well-being — a culture where every member of the…
May 29, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
May 29, 2025
Foley Viewpoints
Supreme Court Clarifies Scope of Federal Fraud Statutes in Connection with False DBE Reporting on Federally Funded Projects
On May 22, 2025, the U.S. Supreme Court issued a significant decision in Kousisis v. United States, affirming a six-year prison sentence for a contractor convicted of federal wire fraud for misrepresenting use of a disadvantaged business enterprise supplier on a project.